Colinz Laboratories Ltd vs Venmax Drugs Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Colinz Laboratories Ltd is ₹ 44.15 as of 04 May 10:14 . The P/E Ratio of Colinz Laboratories Ltd changed from 12.9 on March 2021 to 36.8 on March 2025 . This represents a CAGR of 23.33% over 5 yearsThe P/E Ratio of Venmax Drugs & Pharmaceuticals Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Colinz Laboratories Ltd changed from ₹ 3.47 crore on March 2021 to ₹ 33.11 crore on March 2025 . This represents a CAGR of 57.01% over 5 yearsThe Market Cap of Venmax Drugs & Pharmaceuticals Ltd changed from ₹ 14.94 crore on March 2025 to ₹ 14.94 crore on March 2025 . This represents a CAGR of 0.00% over 1 years The revenue of Colinz Laboratories Ltd for the Mar '26 is ₹ 1.92 crore as compare to the Dec '25 revenue of ₹ 1.51 crore. This represent the growth of 27.15% The revenue of Venmax Drugs & Pharmaceuticals Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 1.62 crore. This represent the decline of -100% The ebitda of Colinz Laboratories Ltd for the Mar '26 is ₹ 0.27 crore as compare to the Dec '25 ebitda of ₹ 0.18 crore. This represent the growth of 50% The ebitda of Venmax Drugs & Pharmaceuticals Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0.04 crore. This represent the decline of -100% The net profit of Colinz Laboratories Ltd changed from ₹ 0.14 crore to ₹ 0.17 crore over 8 quarters. This represents a CAGR of 10.19% The net profit of Venmax Drugs & Pharmaceuticals Ltd changed from ₹ 0.01 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The Dividend Payout of Colinz Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Venmax Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Colinz Laboratories Ltd

Colinz Laboratories Limited, was incorporated as a Private Limited Company in 1986.
The Company got converted into Public Limited Company in 1995, which however started their manufacturing and marketing activities in 1995.
The Company manufactures a wide variety of pharmaceutical formulations in the dosage forms of tablets, capsules, granules, liquid orals, injectables, ointments, creams etc.
The Company is having certain specialized products for Gynaecology, Cardiology, Gastroentrology etc.
Since, the Company falls under the MSME sector, it established reputation as a quality supplier of medicines in the domestic market, wherever the Company has operation. Apart from this, the Company has a WHO compliant plant at Sinnar.

About Venmax Drugs & Pharmaceuticals Ltd

Venmax Drugs & Pharmaceuticals Limited, (VDPL) was initially incorporated as Private Company as 'Yenkay Medico Private Limited', on 28 September, 1998.
The Company thereafter changed its name to 'Yenkey Drugs & Pharmaceuticals Private Limited' on 18 January, 1995.
It became a Public Limited Company on February 3, 1995 as 'Yenkey Drugs & Pharmaceuticals Limited'.
Finally, the Company changed its name to 'Venmax Drugs & Pharmaceuticals Limited' on April 13, 2009. For the past six months, Company focused on establishing chain of Medical Stores with a brand name as 'Ananya Pharma' under the Venmax Drugs & Pharma Limited, with the backing support of Formulations plant (Suzichem Labs).
At present, Company is engaged in the business of pharmaceutical products, drug intermediaries & API's etc. The Company is developing the oncology products in R&D.

FAQs for the comparison of Colinz Laboratories Ltd and Venmax Drugs & Pharmaceuticals Ltd

Which company has a larger market capitalization, Colinz Laboratories Ltd or Venmax Drugs & Pharmaceuticals Ltd?

Market cap of Colinz Laboratories Ltd is 5 Cr while Market cap of Venmax Drugs & Pharmaceuticals Ltd is 28 Cr

What are the key factors driving the stock performance of Colinz Laboratories Ltd and Venmax Drugs & Pharmaceuticals Ltd?

The stock performance of Colinz Laboratories Ltd and Venmax Drugs & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Colinz Laboratories Ltd and Venmax Drugs & Pharmaceuticals Ltd?

As of May 4, 2026, the Colinz Laboratories Ltd stock price is INR ₹46.1. On the other hand, Venmax Drugs & Pharmaceuticals Ltd stock price is INR ₹24.51.

How do dividend payouts of Colinz Laboratories Ltd and Venmax Drugs & Pharmaceuticals Ltd compare?

To compare the dividend payouts of Colinz Laboratories Ltd and Venmax Drugs & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.